Health insurers have long promoted switching from brand-name medicines to cheaper generics, but now more of them are going further: urging people to take different drugs altogether. ...more

December 13, 2008

The government closed U.S. borders Tuesday to more than 30 generic drugs, including popular antibiotics and cholesterol medicines, made by India's biggest pharmaceutical company, citing poor quality in two of its factories. ...more

September 17, 2008

Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer. ...more

August 22, 2008

The makers of popular cholesterol drugs Vytorin and Zetia - Merck & Co. and Schering-Plough Corp. - are being sued in states across the country over allegations that they misled consumers into thinking the drugs were more effective than generic ones. ...more

January 25, 2008

A popular cholesterol-lowering drug failed to help slow the buildup of artery-clogging plaque in a long-awaited study, the companies that market the medication said Monday, raising questions about whether its use should be limited. ...more

January 15, 2008